Kayne Anderson Rudnick Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1
Closed -$22 996
2023
Q4
$22 Hold
1
﹤0.01% 958
2023
Q3
$19 Hold
1
﹤0.01% 881
2023
Q2
$25 Hold
1
﹤0.01% 877
2023
Q1
$26 Buy
+1
New +$27 ﹤0.01% 780
2022
Q4
Sell
-203
Closed -$5K 696
2022
Q3
$5K Buy
+203
New +$7.12K ﹤0.01% 586
2021
Q4
Sell
-83
Closed -$11K 656
2021
Q3
$11K Sell
83
-205,870
-100% -$30M ﹤0.01% 517
2021
Q2
$34.2M Sell
205,953
-116,069
-36% -$18.8M 0.08% 166
2021
Q1
$58.5M Buy
322,022
+9,529
+3% +$2.21M 0.16% 130
2020
Q4
$62.5M Sell
312,493
-60,888
-16% -$12.4M 0.18% 124
2020
Q3
$81.9M Buy
373,381
+75,072
+25% +$15.9M 0.3% 90
2020
Q2
$56.9M Buy
298,309
+27,411
+10% +$4.8M 0.24% 98
2020
Q1
$42M Buy
270,898
+68,082
+34% +$7.92M 0.24% 92
2019
Q4
$17M Buy
202,816
+23,673
+13% +$1.8M 0.08% 147
2019
Q3
$12.1M Buy
179,143
+45,386
+34% +$2.99M 0.06% 168
2019
Q2
$8.88M Buy
133,757
+37,959
+40% +$2.21M 0.05% 181
2019
Q1
$5.33M Buy
95,798
+12,933
+16% +$790K 0.03% 201
2018
Q4
$4.11M Buy
82,865
+8,072
+11% +$494K 0.03% 219
2018
Q3
$6.46M Buy
74,793
+4,914
+7% +$350K 0.04% 194
2018
Q2
$4.06M Buy
69,879
+36,329
+108% +$1.77M 0.03% 212
2018
Q1
$1.35M Sell
33,550
-280
-0.8% -$10.6K 0.01% 287
2017
Q4
$1.18M Buy
33,830
+13,000
+62% +$432K 0.01% 285
2017
Q3
$691K Buy
+20,830
New +$683K 0.01% 306

Other funds holding TDOC

Kayne Anderson Rudnick Investment Management's TDOC Position: Q1 2024 in Review

Kayne Anderson Rudnick Investment Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 1 share — an estimated $22 sold.

Kayne Anderson Rudnick Investment Management first reported a position in TDOC in Q3 2017 and held it in 22 quarters. The position peaked at $81.9M in Q3 2020. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Kayne Anderson Rudnick Investment Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 1 Teladoc Health share in Q1 2024, an estimated $22.
  • Kayne Anderson Rudnick Investment Management first reported a position in Teladoc Health in Q3 2017 and held it in 22 quarters.
  • Kayne Anderson Rudnick Investment Management's Teladoc Health position peaked at $81.9M in Q3 2020.
  • 427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2024, filed 14 May 2024.